Intravenous Ribavirin Is a Safe and Cost-effective Treatment for Respiratory Syncytial Virus Infection After Lung Transplantation
Author:
Allan R. Glanville,Andrew I.R. Scott,Judith M. Morton,Christina L. Aboyoun,Marshall L. Plit,Ian W. Carter,Monique A. Malouf
Publication:
The Journal of Heart and Lung Transplantation
Copyright © 2005 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.